| Advisory panel recommends FDA to allow the continued use of ESA labels - The Money Times |
|
|
The Money TimesThe current prescribing guidelines for darbepoetin use among chronic kidney disease patients not on dialysis was highly endorsed by the FDA's Cardiovascular ... read more |